TLOG

TETRALOGIC PHARMS CORP by TetraLogic Pharmaceuticals Corporation (TLOG)

About TETRALOGIC PHARMS CORP by TetraLogic Pharmaceuticals Corporation (TLOG)

TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel small molecule therapeutics in oncology and infectious diseases. Its products include Birinapant and SHAPE. The company was founded by Yigong Shi, John M. Gill and Mark A. McKinlay in July 2001 and is headquartered in Malvern, PA.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
0
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--

TETRALOGIC PHARMS CORP by TetraLogic Pharmaceuticals Corporation News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
0
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--